Acacia Subsidiary Acquires Patents for Medical Devices
Shape Memory Alloys
January 26, 2010 06:03 AM Eastern Time
NEWPORT BEACH, Calif.--(EON: Enhanced Online News)--Acacia Research Corporation (Nasdaq:ACTG) announced today t
has acquired patents for medical devices using shape memory alloys.
"Acacia continues to grow its base of future revenues by adding new patent portfolios,” commented Paul Ryan, Acacia Chairman a
licensing success grows, more patent owners are selecting us as their partner for the licensing of their patented technologies,” conclu
The patented technology generally relates to using shape memory alloys such as Nitinol to fabricate medical devices that utilize the
and/or superelasticity of the alloy. The technology can be used to improve cardiovascular and endoscopic procedures such as embo
(inferior vena cava filters, carotid filters, etc.) and kidney stone retrieval.
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research’s subsidiaries develop, acquire, and license patented technologies. Acacia Research’s subsidiaries control over 14
portfolios, covering technologies used in a wide variety of industries.
Information about Acacia Research is available at www.acaciatechnologies.com and www.acaciaresearch.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This news release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private S
Litigation Reform Act of 1995.These statements are based upon our current expectations and speak only as of the date her
become the licensing partner for companies, and our actual results may differ materially and adversely from those express
forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affect
companies, theability to successfully develop licensing programs and attract new business, rapid technological change in re
changes in demand for current and future intellectual property rights, legislative, regulato